Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

MIMetiCO

Financiado

Cerrado

Multiscale Integrative Approach for Corneal Biomechanics to Assess Corneal Cross...

Multiscale Integrative Approach for Corneal Biomechanics to Assess Corneal Crosslinking Approximately 250 million people worldwide are visually impaired, and this has great economic and social impact. One of the pathologies of vision loss is keratoconus, in which the mechanical balance of the cornea depending on intr... ver más

31/08/2020

UNIVERSITAET BERN

175K€

Presupuesto del proyecto: 175K€

Líder del proyecto

UNIVERSITAET BERN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2020-08-31

MSCA-IF-2017: Individual Fellowships

I+D

Cerrada hace 7 años

0% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

UNIVERSITAET BERN

175.42K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

POPCORN Development of corneal biomechanical model. Dynamic topograp... 1M€ Cerrado

DPI2017-84047-R MODELADO PERSONALIZADO IN-SILICO DEL GLOBO OCULAR. AYUDA AL... 121K€ Cerrado

IJC2018-037508-I Assessment of corneal biomechanics using air-puff corneal de... 93K€ Cerrado

TIN2010-20999-C04-03 MODELIZACION BIOMECANICA DE TEJIDOS APLICADO A CIRUGIA ASIST... 31K€ Cerrado

MICROCORNEA In vivo microstructure of the cornea implications for visio... 246K€ Cerrado

RYC-2016-20471 Propiedades ópticas y biomecánicas de la córnea y su impacto... 309K€ Cerrado

Duración del proyecto: 28 meses Fecha Inicio: 2018-04-12
Fecha Fin: 2020-08-31

Líder del proyecto

UNIVERSITAET BERN No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Presupuesto del proyecto 175K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto Approximately 250 million people worldwide are visually impaired, and this has great economic and social impact. One of the pathologies of vision loss is keratoconus, in which the mechanical balance of the cornea depending on intraocular pressure and internal stresses in corneal tissue becomes imbalanced, which can result in a corneal protrusion. Corneal crosslinking (CXL) is a clinical treatment that increases the overall mechanical stiffness of the cornea by inducing chemical bounding between collagen molecules. CXL is the present of halting corneal ectasias, and the future of noninvasive refractive surgery. However, its micro/nano-mechanisms are not completely understood. Moreover, CXL is usually applied uniformly in corneal treatments, which can result in over-stiffening and unexpected postsurgical outcomes. Ophthalmology can benefit from in silico modeling to plan and improve such interventions. However, current computational models are mainly macroscopic and cannot simulate complex phenomena involved in CXL. Multiscale computational models could improve clinical strategies by including information at different scales. MIMetiCO’s goal is to combine experiments and modelling at different scales to provide a multiscale characterization of corneal biomechanics before and after CXL. This characterization will rely on both ground-breaking and well-established technologies that include confocal microscopy, biochemical assessment, and mechanical inflation tests to determine morphological (orientation and density of fibrils), biochemical (amount of intermolecular crosslinks), and mechanical features of the cornea. MIMetiCO will use this information to calibrate the first in silico model of the cornea using a multiscale structural approach to build a virtual framework to simulate potential CXL treatments. MIMetiCO is the next step in ophthalmology, which has the potential to bring into being a new generation of clinical assessment.

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores